332 related articles for article (PubMed ID: 9421475)
1. Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection.
Caruso A; Licenziati S; Canaris AD; Cantalamessa A; Fiorentini S; Ausenda S; Ricotta D; Dima F; Malacarne F; Balsari A; Turano A
J Clin Invest; 1998 Jan; 101(1):137-44. PubMed ID: 9421475
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
3. The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.
Eylar EH; Báez I; Lefranc CE; Colón-Martínez SL; Rodríguez V; Yamamura Y; Rodriguez N
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):989-93. PubMed ID: 9449531
[TBL] [Abstract][Full Text] [Related]
4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
5. C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease.
Peritt D; Sesok-Pizzini DA; Schretzenmair R; Macgregor RR; Valiante NM; Tu X; Trinchieri G; Kamoun M
J Immunol; 1999 Jun; 162(12):7563-8. PubMed ID: 10358213
[TBL] [Abstract][Full Text] [Related]
6. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
Lepej SZ; Begovac J; Vince A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
[TBL] [Abstract][Full Text] [Related]
7. Potential role of CD8+CD28- T lymphocytes in immune activation during HIV-1 infection.
Vivar N; Thang PH; Atlas A; Chiodi F; Rethi B
AIDS; 2008 May; 22(9):1083-6. PubMed ID: 18520354
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
10. Depletion of pro-inflammatory CD161(+) double negative (CD3(+)CD4(-)CD8(-)) T cells in AIDS patients is ameliorated by expansion of the γδ T cell population.
Singleterry WL; Henderson H; Cruse JM
Exp Mol Pathol; 2012 Feb; 92(1):155-9. PubMed ID: 22100877
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis.
Hooper M; Kallas EG; Coffin D; Campbell D; Evans TG; Looney RJ
J Rheumatol; 1999 Jul; 26(7):1452-7. PubMed ID: 10405929
[TBL] [Abstract][Full Text] [Related]
12. Suppressed proliferative response and interleukin-2 production in hispanic HIV+ and AIDS T-cell subsets.
Eylar EH; Báez I; Vázquez A; Colón-Martínez SL; Yamamura Y
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S25-33. PubMed ID: 8574145
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution following autologous transfers of CD3/CD28 stimulated CD4(+) T cells to HIV-infected persons.
Bernstein WB; Cox JH; Aronson NE; Tracy L; Schlienger K; Ratto-Kim S; Garner R; Cotte J; Zheng Z; Winestone L; Liebig C; Galley LM; Connors M; Birx DL; Carroll RG; Levine BL
Clin Immunol; 2004 Jun; 111(3):262-74. PubMed ID: 15183147
[TBL] [Abstract][Full Text] [Related]
14. Transient T cell receptor beta-chain variable region-specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping.
Soudeyns H; Champagne P; Holloway CL; Silvestri GU; Ringuette N; Samson J; Lapointe N; Sékaly RP
J Infect Dis; 2000 Jan; 181(1):107-20. PubMed ID: 10608757
[TBL] [Abstract][Full Text] [Related]
15. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
[TBL] [Abstract][Full Text] [Related]
16. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
17. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Fas antigen in patients infected with human immunodeficiency virus.
McCloskey TW; Oyaizu N; Kaplan M; Pahwa S
Cytometry; 1995 Jun; 22(2):111-4. PubMed ID: 7587741
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
20. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
